Nidek Co., Ltd.
$29.8K 11 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Surgical Fusion Inc.
Surgical Fusion Inc. reported $29,842.14 across General Payments, Research, and Ownership to 7 physicians and teaching hospitals across 7 transactions.
- $29.8K Below-median payer
- All-tracks total
- 7 Below-median volume
- Transactions
- 7 Below-median reach
- Recipients
- +$7.9K
- General Payments vs PY2023
Surgical Fusion Inc. reported $29,842.14 across all CMS Open Payments tracks (General + Research + Ownership) to 7 physicians and teaching hospitals in Program Year 2024 - ranking #1470 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $29,842.14, averaging $4.3K per recipient.
Surgical Fusion Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
13/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer surgical-fusion-inc Surgical Fusion Inc.
$29.8K · #1470/1,925 · 0.0% industry · PY2024
- TOT $29.8K
- RANK #1470
- SHARE 0.0%
- TXN 7
- RCP 7
- CAT 2
- GEN $29.8K
- ΔGEN +$7.9K
- TOP1 33.4%
- PY 2024
Volume peers
Nearest volume peer: Nidek Co., Ltd. ($29.8K)
Surgical Fusion Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Surgical Fusion Inc.'s CMS-reported General Payments increased by $7.9K (+35.9%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2023: SURGICAL FUSION INC.PY2024: Surgical Fusion Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $21,955.00
- PY2024
- $29,842.14
What the Data Shows for Surgical Fusion Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Surgical Fusion Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
Of the 2 general-payment categories charted below, "Royalty or License" is the largest at $18.7K across 3 transactions, 62.6% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Royalty or License" leads Surgical Fusion Inc.'s 2-category general-payment breakdown at $18.7K, 62.6% of the reported total.
How Surgical Fusion Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $18.7K | 3 | 62.6% |
| Consulting Fee | $11.2K | 4 | 37.4% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $29,842.14 (100.0%) of $29,842.14 in this company's General Payments records across 5 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Surgical Fusion Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Steven Roser
$9,954.60 across 3 reported transactions
- 2
Oliver Schipper
$8,073.96 across 1 reported transactions
- 3
Jonathan Kaplan
$5,733.58 across 1 reported transactions
- 4
Tyler Gonzalez
$4,880.00 across 1 reported transactions
- 5
Shane Hollawell
$1,200.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Surgical Fusion Inc. ranks #1470 of 1,925 by total payments (bottom 24% by spend) but is notably more concentrated than that alone would suggest -- #649 of 1,838 by HHI (top 35% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Avirmax Biopharma, Inc : $631.49 total payments, HHI 2519
- IBSA Institut Biochimique SA : $50.0K total payments, HHI 2512
- Ignite Orthomotion LLC : $27.3K total payments, HHI 2504
- NuMED for Children, LLC : $120.0K total payments, HHI 2500
- Clozex Medical Inc : $532.74 total payments, HHI 2499
- Veran Medical Technologies, Inc. : $3.6K total payments, HHI 2498
- Surgical Fusion Inc. (this company) : $29.8K total payments, HHI 2497
- Corentec America,Inc. : $280.2K total payments, HHI 2497
- Civica, Inc. : $1.1K total payments, HHI 2493
- Atlas Spine, Inc. : $31.3K total payments, HHI 2488
- Agfa HealthCare Corporation : $400.9K total payments, HHI 2487
- Zap Surgical Systems, Inc. : $43.0K total payments, HHI 2486
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Surgical Fusion Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Surgical Fusion Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Surgical Fusion Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Jubilant Therapeutics Inc
$30.0K 2 recipients
Compare payment profiles
Vector Surgical, LLC
$29.7K 82 recipients
Compare payment profiles
MY01 Inc.
$29.5K 290 recipients
Compare payment profiles
Intelivation Technologies, LLC
$30.3K 43 recipients
Compare payment profiles
3B Medical, Inc.
$29.3K 495 recipients
Compare payment profiles
Put this to use
Surgical Fusion Inc. ranks #1470 of 1,925 by all-tracks total payments, led by "Royalty or License".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Royalty or License" spend across every manufacturer, not just Surgical Fusion Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.